C4 THERAPEUTICS INC.
6.0400
07-November-24 14:59:54
15 minutes delayed
Stocks
+0.0700
+1.17%
Today's range
5.9300 - 6.2500
ISIN
N/A
Source
NASDAQ
-
05 Mar 2024 15:30:00 By Nasdaq GlobeNewswire
-
04 Mar 2024 06:00:00 By Nasdaq GlobeNewswire
-
22 Feb 2024 06:00:00 By Nasdaq GlobeNewswire
-
09 Jan 2024 15:01:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics Announces Closing of $25 Million Equity Investment by Betta Pharmaceuticals
04 Jan 2024 15:01:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
04 Jan 2024 06:00:00 By Nasdaq GlobeNewswire
-
12 Dec 2023 15:01:00 By Nasdaq GlobeNewswire
-
12 Dec 2023 06:00:00 By Nasdaq GlobeNewswire
-
28 Nov 2023 06:00:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics Strengthens Board of Directors with Owen Hughes Appointment
20 Nov 2023 06:00:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights
01 Nov 2023 06:00:00 By Nasdaq GlobeNewswire
-
11 Oct 2023 06:00:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics Announces Chief Financial Officer Succession
05 Sep 2023 15:01:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights
08 Aug 2023 06:00:01 By Nasdaq GlobeNewswire
-
C4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17 Jul 2023 06:00:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics Appoints Leonard Reyno, M.D., as Chief Medical Officer
20 Jun 2023 06:00:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights
04 May 2023 06:00:01 By Nasdaq GlobeNewswire